Enhanced Recovery After Laparoscopic Colorectal Surgery Study

NCT ID: NCT04091815

Last Updated: 2020-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-25

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will assess the impact on quality of care after implementation of the ERAS (Enhanced Recovery After Surgery) protocol for laparoscopic colorectal surgery in Vilnius University Hospital Santaros klinikos. The primary goal of this study is to compare efficacy of two different types of anaesthesia - general and combined (spinal and general), efficacy of multimodal analgesia in both groups, need for rescue analgetics, time to bowel movement, time to ambulation. We also aim to study overall patient satisfaction and measure health-related quality of life, from date of randomisation until the date of hospital discharge, 30 days, 3 months and 6 months post-discharge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recovery After Surgery (ERAS) protocol is a multimodal perioperative care pathway designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery, now widely accepted in laparoscopic colorectal surgery.

In laparoscopic colorectal surgery, the ERAS protocol involves an accurate interview with the patient in the preoperative phase aimed at smoking and alcohol cessation, the reduction of preoperative fasting with administration of oral carbohydrates before surgery, use of intestinal preparation for selected cases only, the prophylaxis of thromboembolism, a correct antibiotic prophylaxis, the prevention of intraoperative hypothermia and hypotension, prevention of volume overload, preference for minimally invasive surgery, multimodal analgesia with reduced opioid requirements, local anaesthetics for wound infiltration, prevention of postoperative nausea and vomiting, very limited use of the nasogastric tube, early removal of the urinary catheter, multimodal analgesia to minimize opiate consumption, early postoperative mobilization and early postoperative feeding, to promote rapid recovery of gastrointestinal functions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparoscopic Colorectal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

I group - general anaesthesia

General anesthesia, induction with fentanyl, propofol, roqurium. Maintenance - sevoflurane (BIS ranges 40 - 60), opioids (fentanyl and morphine), roqurium. Intraoperative fluid administration - 2000ml sterofundine, 500ml Gelaspan. 75mg intravenous diclofenac sodium on anesthesia induction, 1000mg intravenous acetaminophen at the start of wound closure. Surgical site infiltration, bupivacaine, 0.25%-10 ml, after the last suture.

Group Type ACTIVE_COMPARATOR

Type of anaesthesia

Intervention Type OTHER

Two different types of anesthesia general vs combined (spinal and general)

II group - combined - spinal and general anaesthesia

Spinal anesthesia: L3-4 interspace, 27G needle, bupivacaine hyperbaric, 16 mg, morphine sulfate 0.1% - 0.1ml.

General anesthesia, induction with fentanyl, propofol, roqurium. Maintenance - sevoflurane (BIS ranges 40 - 60), roqurium. Intraoperative fluid administration - 2000ml sterofundine, 500ml Gelaspan. 75mg intravenous diclofenac sodium on anesthesia induction, 1000mg intravenous acetaminophen at the start of wound closure. Surgical site infiltration, bupivacaine, 0.25%-10 ml, after the last suture.

Group Type EXPERIMENTAL

Type of anaesthesia

Intervention Type OTHER

Two different types of anesthesia general vs combined (spinal and general)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Type of anaesthesia

Two different types of anesthesia general vs combined (spinal and general)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age and older.
* scheduled for laparoscopic colorectal surgery.
* patient informed and having accepted the principle of enhanced recovery after surgery.
* patient written consent will be obtained preoperatively for eligible study participants.

Exclusion Criteria

Preoperative:

* patients who can not comply with the ERAS protocol because they do not understand the language or has a cognitive disorder.
* patients with a documented allergy to nonsteroidal anti-inflammatory drugs and acetaminophen.
* preoperative renal insufficiency (creatinine clearance less than or equal to 30ml/min) or hemodialysis.
* patients with a history of hepatic impairment.
* chronic pain condition that required daily opioid dependence.

Operative:

* conversion to laparotomy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vilnius University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Egle Kontrimaviciute

MD, PhD, Assoc Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jurate Sipylaite, MD, PhD

Role: STUDY_CHAIR

Vilnius University, Faculty of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vilnius University Hospital Santaros Clinics

Vilnius, , Lithuania

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Lithuania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Egle Kontrimaviciute, MD, PhD

Role: CONTACT

0037052365264

Agne Jankuviene, MD

Role: CONTACT

0037052365264

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Egle Kontrimaviciute, Assoc. Prof

Role: primary

+37052365264

Agne Jankuviene, MD

Role: backup

+37052365264

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19BMT32

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.